Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Epidemiologic and Clinical Feature Study of Non-Small Cell Lung Cancer (NSCLC) Patients With ALK Positive in China

NCT02042105 is registered in ClinicalTrials.gov with Guangdong Association of Clinical Trials as lead sponsor.

NCT NCT02042105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02042105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Epidemiologic and Clinical Feature Study of Non-Small Cell Lung Cancer (NSCLC) Patients With ALK Positive in China
Lead sponsor
Guangdong Association of Clinical Trials
Phase
Observational
Overall status
Completed
Start date
November 11, 2013
Completion date
July 6, 2016
Enrollment
3,649 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

non-small-cell lung cancer